Open Access
Issue
J Oral Med Oral Surg
Volume 24, Number 4, December 2018
Page(s) 182 - 186
Section Cas clinique et revue de la littérature / Up-to date review and case report
DOI https://doi.org/10.1051/mbcb/2018007
Published online 17 December 2018
  1. Jaffe HL. Giant-cell reparative granuloma, traumatic bone cyst, and fibrous (fibro-oseous) dysplasia of the jawbones. Oral Surg Oral Med Oral Pathol 1953;6:159–175. [CrossRef] [PubMed] [Google Scholar]
  2. Auclair PL, Cuenin P, Kratochvil FJ, Slater LJ, Ellis GL. A clinical and histomorphologic comparison of the central giant cell granuloma and the giant cell tumor. Oral Surg Oral Med Oral Pathol 1988;66:197–208. [CrossRef] [PubMed] [Google Scholar]
  3. De Lange J, van den Akker HP, Klip H. Incidence and disease-free survival after surgical therapy of central giant cell granulomas of the jaw in the Netherlands: 1990–1995. Head Neck 2004;26:792–795. [CrossRef] [PubMed] [Google Scholar]
  4. Chuong R, Kaban LB, Kozakewich H, Perez-Atayde A. Central giant cell lesions of the jaws: a clinicopathologic study. J Oral Maxillofac Surg 1986;44:708–713. [CrossRef] [PubMed] [Google Scholar]
  5. De Lange J, Van den Akker HP. Clinical and radiological features of central giant-cell lesions of the jaw. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2005;99:464–470. [CrossRef] [PubMed] [Google Scholar]
  6. Krammer U, Wimmer K, Wiesbauer P, Rasse M, Lang S, Mullner-Eidenböck A, Frisch H. Neurofibromatosis 1: a novel NF1 mutation in an 11-year-old girl with a giant cell granuloma. J Child Neurol 2003;18:371–373. [CrossRef] [PubMed] [Google Scholar]
  7. Harmon M, Arrigan M, Toner M, O’Keeffe SA. A radiological approach to benign and malignant lesions of the mandible. Clin Radiol 2015;70:335–350. [CrossRef] [PubMed] [Google Scholar]
  8. Marx R, Stern D. Oral and maxillofacial pathology, Chicago: Quintessence Publishing Co Ltd, 2002: 783–789. [Google Scholar]
  9. Raubenheimer EJ, Noffke CE, Mohamed A. Expansive jaw lesions in chronic kidney disease: review of the literature and a report of two cases. Oral Surg Oral Med Oral Pathol Oral Radiol 2015;119:340–345. [CrossRef] [PubMed] [Google Scholar]
  10. Chami LB, El Omri N, El Qatni M, El Wady W, El Mohtarim B. Brown tumor of the palate as first manifestation of primary hyperparathyroidism: a case report. Med Buccale Chir Buccale 2011;17:287–291. [CrossRef] [Google Scholar]
  11. Mohammed Farouk SH, Ihsane Ben Yahya La tumeur brune due à une hyperparathyroïdie secondaire: à propos d’un cas clinique et revue de la littérature. Med Buccale Chir Buccale 2017;23:61–64. [CrossRef] [Google Scholar]
  12. Gupta B, Stanton N, Coleman H, White C, Singh J. A novel approach to the management of a central giant cell granuloma with denosumab: a case report and review of current treatments. J Craniomaxillofac Surg 2015;43:1127–1132. [CrossRef] [PubMed] [Google Scholar]
  13. O'Connell JE, Bowe C, Murphy C, Toner M, Kearns GJ. Aggressive giant cell lesion of the jaws: a review of management options and report of a mandibular lesion treated with denosumab. Oral Surg Oral Med Oral Pathol Oral Radiol 2015;120:e191–e198. [CrossRef] [PubMed] [Google Scholar]
  14. Yanik S, Aras MH. Management of central giant cell granuloma of mandible using intralesional corticosteroids: case report and review of literature. J Oral Maxillofac Surg 2013;71:721–722. [CrossRef] [PubMed] [Google Scholar]
  15. Schreuder WH, van den Berg H, Westermann AM, Peacock ZS, de Lange J. Pharmacological and surgical therapy for the central giant cell granuloma: a long-term retrospective cohort study. J Craniomaxillofac Surg 2017;45:232–243. [CrossRef] [PubMed] [Google Scholar]
  16. Tabrizi R, Fardisi S, Zamiri B, Amanpour S, Karagah T. Can calcitonin nasal spray reduce the risk of recurrence of central giant cell granuloma of the jaws? A double-blind clinical trial. Int J Oral Maxillofac Surg 2016;45:756–759. [CrossRef] [PubMed] [Google Scholar]
  17. Xu SF, Adams B, Yu XC, Xu M. Denosumab and giant cell tumour of bone-a review and future management considerations. Curr Oncol 2013;20:e442–e447. [CrossRef] [PubMed] [Google Scholar]
  18. Thomas D, Henshaw R, Skubitz K, Chawla S, Staddon A, Blay JY, Roudier M, Smith J, Ye Z, Sohn W, Dansey R, Jun S. Denosumab in patients with giant-cell tumour of bone: an open-label, phase 2 study. Lancet Oncol 2010;11:275–280. [CrossRef] [PubMed] [Google Scholar]
  19. Thomas DM. RANKL, denosumab, and giant cell tumor of bone. Curr Opin Oncol 2012;24:397–403. [CrossRef] [PubMed] [Google Scholar]
  20. Schreuder WH, Coumou AW, Kessler PA, de Lange J. Alternative pharmacologic therapy for aggressive central giant cell granuloma: denosumab. J Oral Maxillofac Surg 2014;72: 1301–1309. [CrossRef] [PubMed] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.